Company news

Tvardi Therapeutics, Inc. news in 2025

Tvardi Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 18, 2025

Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update

November 13, 2025

Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

November 4, 2025

Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis

October 13, 2025

Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference

August 21, 2025

Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update

August 14, 2025

Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

July 15, 2025

Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis

May 27, 2025

Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update

May 13, 2025

Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

May 6, 2025

Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics

April 13, 2025

Decks in 2025